Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,520,540
+$102,682 QoQ
Shares Held
11,833
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,788
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aureus Asset Management, LLC holds $14,021,737 across 9 Drug Manufacturers - General names. MRK ranks #5 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,359 | $4,028,885 | |
| 2 | JNJ |
Johnson & Johnson
|
9,201 | $2,336,777 | |
| 3 | AMGN |
Amgen Inc
|
4,987 | $1,805,892 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
11,833 | $1,520,540 | |
| 6 | NVO |
Novo Nordisk A S
|
27,220 | $1,304,926 | |
| 7 | NVS |
Novartis AG
|
5,586 | $875,437 | |
| 8 | AZN |
Astrazeneca PLC
|
1,105 | $209,530 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,520,540 | 11,833 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,417,858 | 11,787 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,230,278 | 11,688 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $862,296 | 10,274 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $948,415 | 11,981 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,230,225 | 58,269 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,333,846 | 43,565 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,791,219 | 50,997 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,183,134 | 41,867 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,463,736 | 33,829 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,268,992 | 11,640 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,171,982 | 11,384 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,191,055 | 10,322 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,086,880 | 10,216 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,134,574 | 10,226 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $896,681 | 10,412 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,120,752 | 12,293 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $973,359 | 11,863 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $885,421 | 11,553 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $809,836 | 10,782 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $817,518 | 10,512 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $794,412 | 10,305 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,313,789 | 16,061 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,281,661 | 15,451 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,366,499 | 17,671 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,472,938 | 19,144 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||